Imaging Diagnostic Systems Highlights New Clinical Results At RSNA 2005

FORT LAUDERDALE, Fla., Nov. 8 /PRNewswire-FirstCall/ -- Imaging Diagnostic Systems, Inc., announced that IDSI will display new clinical results and feature the CT Laser Mammography System at RSNA 2005, November 27 - December 2, in Chicago, Illinois. IDSI will be located at Booth #5139 in the South Hall.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO )

“We have made impressive clinical progress since last year’s RSNA,” stated Tim Hansen, IDSI Chief Executive Officer. “Earlier this year, our first peer- reviewed CT Laser Mammography paper was published. Our exam volume has risen to over 6,000 as a result of the efforts of our international users and our research partners. Many of these new clinical cases will be presented at this important global imaging venue. Our results underscore our extensive experience and leadership in laser optical breast imaging. We are looking forward to sharing these developments with breast and molecular imaging specialists.”

RSNA 2005 is the 91st Scientific Assembly and Annual Meeting of the Radiological Society of North America. A forum for radiologic science and technology, RSNA features scientific papers, posters, courses, lectures, symposia, and exhibits. In 2004, the annual meeting attracted over 60,000 attendees.

The CT Laser Mammography (CTLM(R)) system is the first patented breast imaging system that utilizes state-of-the-art laser technology and patented algorithms to create 3-D cross-sectional images of the breast. It is a non- invasive, painless examination that does not expose the patient to radiation or require breast compression. Imaging Diagnostic Systems has received CE Marking, CMDCAS (Canada), Canadian License, China SFDA approval, UL listing, ISO 9001:2000-13488 certification and FDA export certification for its CT Laser Breast Imaging system. The Company is seeking PreMarket Approval (PMA) from the Food and Drug Administration (FDA) for its CTLM(R) system to be used as an adjunct to mammography.

Please visit Imaging Diagnostic Systems’ website at: http://www.imds.com for additional information.

In conjunction with the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future anticipated projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates of future results and there can be no assurance that actual results will not materially differ from expectation. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Company’s filing with the Securities Exchange Commission.

Investor Relations: Rick Lutz 404-261-1196 lcgroup@mindspring.com

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comImaging Diagnostic Systems, Inc.

CONTACT: Investor Relations, Rick Lutz, +1-404-261-1196, orlcgroup@mindspring.com, for Imaging Diagnostic Systems, Inc.